|
|
Today's journal articles
No journal articles today
Do you need further information on any of the agents being evaluated in the trial(s) below? Let us know...
New Clinical Trials
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Previous Journal Entries
Renoprotective Effect of Pioglitazone by the Prevention of Glomerular Hyperfiltration through the Possible Restoration of Altered Macula Densa Signaling in Rats with Type 2 Diabetic Nephropathy.
Two Novel Vitamin D Receptor Modulators with Similar Structures Exhibit Different Hypercalcemic Effects in 5/6 Nephrectomized Uremic Rats.
Small Interfering RNA Targeting Toll-Like Receptor 9 Protects Mice against Polymicrobial Septic Acute Kidney Injury.
A Novel Mouse Model of Chronic Inflammatory and Overactive Bladder by a Single Intravesical Injection of Hydrogen Peroxide.
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis.
Factors Associated With a Better Therapeutic Effect of Solifenacin in Patients With Overactive Bladder Syndrome.
Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis.
The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial.
A phase II dose-ranging study of mirabegron in patients with overactive bladder.
The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS.
Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis.
Effect of metformin against cisplatin induced acute renal injury in rats: A biochemical and histoarchitectural evaluation.
Ejaculatory Responses are Inhibited by a New Chemical Entity, DA-8031, in Preclinical Rodent Models of Ejaculation.
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).
Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: A meta-analysis of randomized controlled trials.
Desmopressin add-on therapy for refractory nocturia in men receiving alpha-blockers for lower urinary tract symptoms.
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
|
Today's News Items
No news items selected today
Training Courses & Meetings
No events listed
Previous News Items
No previous news items today
|
If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, 
, links through to full analyses relating to pharmaceutical/market developments relating to this work